Skip to main content
. 2018 Mar 12;21(2):325–334. doi: 10.1007/s10456-018-9598-5

Table 2.

Concentrations of VEGF and activation markers of platelets and endothelial cells measured in plasma of patients before, 24 h and 3 weeks after start of treatment with sunitinib

Pre-Tx 24 h 3 week
VEGF in PPP (pg/ml) 101 110 218
 N 17 17 9
 SEM 18 23 72
vWF (μg/ml) 16.4 15.6 15.1
 N 15 15 8
 SEM 2.1 2.1 1.7
P-selectin (ng/ml) 120.1 154.3 92.4
 N 15 15 8
 SEM 13.2 32.5 10.4
Beta-TG (ng/ml) 39.1 36.8 26.9
 N 15 15 8
 SEM 5.2 7.4 6.3
RANTES (ng/ml) 4.3 4.1 3.2
 N 15 15 8
 SEM 0.6 0.8 0.7

Vascular endothelial growth factor (VEGF), platelet poor plasma (PPP), von Willebrand factor (vWF), beta-thromboglobulin (beta-TG)

N is the number of patients, SEM is the standard error of mean